WI Harper Group-backed Amwise Diagnostics closes Series B round, achieving accurate prognosis assessment of breast cancer in Asia
WI Harper Group| 2020-02-29 The following article comes from 动脉新医药 Author 徐文娟 Recently, WI Harper-backed Amwise Diagnostics,successfully completed the first close of its B round financing. This financing is led by Jiangsu Simcere Pharmaceutical Co., Ltd, a subsidiary of SimcereHoldings. The funds raised will mainly be used to promote the comprehensive upgrade of the Asian Breast…